Aspiring Business Leaders Worldwide

Pushing feel good philanthropy to its full potential

, / 2752 0

Pushing feel good


In 2007, ElieHassenfeld, a former hedge-fund manager, co-founded GiveWell, a non-profit established to answer doubts of a growing number of donors who wish to know much good their donations will do before deciding which charity to entrust it to. GiveWell researches charities operative in fields where there is corroborative evidence that something wonderful can be done for a much modest donation, such as scaling down the incidence of malaria. The most effective of these operations are published under a list of “best buys”.

In conformity with Alana Petraske, who advises charities and donors for Withers, a law firm, a significant part of the new fever pitch for such impact driven philanthropy stems from donors with business backgrounds who want to see the same effectiveness in their benefaction as in their business.

Billionaire bond investor, Bill Gross is the most recent example of it. The tycoon has said that he will dole his whole fortune out, and praised GiveDirectly, a GiveWelltop pick that makes no provisos cash endowments to the needy in developing nations that he describes as “outperforming the market”.

Venture philanthropy sculpted on venture capitalism, offers an approach to put resources into foundations are trying new ways to deal with solving the same old, existing problems. Big shot benefactors such as the Gates Foundations and USAID, organize competitions for innovative approaches, which are extended if they end up being effective. These bodies look for arduous evaluation – almost half of the projects USAID funds incorporate “gold-standard” randomized controlled trials.

Small donors, as well, are turning out to be wiser in their donations. Their contributions largely exceed those of elite philanthropists and their foundations. According to a 2007 study, American households give away at least $60 billion annually to the needy. In contrast, the Gates Foundation made donations adding up to $3.9 billion in 2014.

The fact that donors are giving careful consideration to the uses their contribution is being put to may appear as a palpable good. But, demanding proof of impact is simply going to push charitable foundations into paying more attention to short-term goals, rather than more important long-term measures of success. Foundations may soon begin to see spearheading medical research as a risky project, naturally gravitating towards projects that promise high levels of success.

Google’s Global Impact Challenge 2013 winner SolarAid, which offersolar lamps that cost as low as $10, and helps families save as much as $70 on kerosene a year, showcases an another kind of drawback. In 2012, its sales began to falter in the region of Malawi and elsewhere.

It was soon found that potential customers in the landlocked country could only afford the product after a successful tobacco harvest, in the month of May. The company began scheduling its sales visits during this month to make the charity a more cost-effective business.

Contributors often look for low overheads in the mixed up notion that this is an intermediary for cost-effective. The real problem is that charities need money for infrastructure, staff as well as research.

Dasra, an India foundation, encourages its rich donors to give foundations cash to be spent on the organization. In 2010, it set up its first giving circle of three donors who collectively pledged $600,000, to be used by small charity to get improve at measuring its impact. Today, the giving circle supports Educate Girls, coveringover 10,000 schools in Rajasthan. More and more charities are realizing that if you want to do well, you need to do well too.

Register today to get full access to:

All articles | Magazine archives | Livestream events | Comments


Register today to get full access to:

All articles | Magazine archives | Livestream events | Comments


Subscribe Plan Details

Register today to get full access to:

All articles | Magazine archives | Livestream events | Comments